Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer
Open Access
- 1 September 2017
- journal article
- review article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 32 (5), 780-789
- https://doi.org/10.3904/kjim.2016.420
Abstract
Thyroid cancer is one of the most common malignancies of endocrine organs, and its incidence rate has increased steadily over the past several decades. Most differentiated thyroid tumors derived from thyroid epithelial cells exhibit slow-growing cancers, and patients with these tumors can achieve a good prognosis with surgical removal and radioiodine treatment. However, a small proportion of patients present with advanced thyroid cancer and are unusually resistant to current drug treatment modalities. Thyroid tumorigenesis is a complex process that is regulated by the activation of oncogenes, inactivation of tumor suppressors, and alterations in programmed cell death. Mitochondria play an essential role during tumor formation, progression, and metastasis of thyroid cancer. Recent studies have successfully observed the mitochondrial etiology of thyroid carcinogenesis. This review focuses on the recent progress in understanding the molecular mechanisms of thyroid cancer relating to altered mitochondrial metabolism.Keywords
Funding Information
- National Research Foundation of Korea (2015R1C1A1A01052432)
- Ministry of Science, ICT and Future Planning
- Chungnam National University
This publication has 77 references indexed in Scilit:
- STAT3 negatively regulates thyroid tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysisCell Research, 2011
- Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 Mutations in Thyroid CancersEndocrine Pathology, 2011
- The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancerMolecular and Cellular Endocrinology, 2010
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicityProceedings of the National Academy of Sciences of the United States of America, 2010
- The cancer genomeNature, 2009
- Thyroid carcinoma: molecular pathways and therapeutic targetsLaboratory Investigation, 2008
- Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumorsProceedings of the National Academy of Sciences of the United States of America, 2007
- The Hallmarks of CancerCell, 2000